dsip risks Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke Peptides in Under 60 Seconds
Description
It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment
for Cabinet"
The primary outcomes were time to complete facial nerve recovery (as assessed by a standardized facial nerve scale) and weekly facial nerve scores, with concomitant symptoms tracked separately
127 The results demonstrated that SEMP-CS/F NPs significantly enhanced epithelial cell proliferation and barrier function, further validating the potential of CS-based NPs for the delivery of therapeutic peptides in GI disorders, including IBD
